한글목차

세계 생체분자 소프트웨어 시장의 미래는 병원, 진료소, 연구 센터 시장에서의 기회로 인해 유망합니다. 세계 생체분자 소프트웨어 시장은 2025년부터 2031년까지 CAGR 15.0%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신약 개발 및 시장 개척을 위한 생체분자 소프트웨어 수요 증가와 맞춤형 의료의 채택 확대입니다.

• Lucintel의 예측에 따르면, 기능별로는 사용 편의성과 기존 인프라와의 호환성으로 인해 Windows 부문이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 용도별로는 환자 데이터 분석, 약물 표적 식별, 맞춤형 치료 계획 개발에 대한 수요 증가로 인해 병원이 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로 보면 제약 및 생명공학 산업이 호조를 보이고 있는 북미가 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

생체분자 소프트웨어 시장의 전략적 성장 기회

생체분자 소프트웨어 시장은 활용 분야 측면에서 다양한 전략적 성장 기회를 제시하고 있습니다. 이러한 분야에 집중하면 시장이 확대되고, 기술이 발전하며, 생체분자 연구와 신약 개발이 촉진될 것입니다.

• 신약개발 : 신약개발 플랫폼의 확장은 고급 분석 및 AI 도구를 프로세스에 통합하여 보다 신속하고 효율적인 의약품 개발을 가능하게함으로써 큰 성장 잠재력을 창출합니다.
• 맞춤형 의료 솔루션 : 맞춤형 의료를 위한 소프트웨어 시스템을 개발함으로써 분자 및 유전자 프로파일에 따라 치료 계획을 맞춤화하여 환자의 치료 결과를 개선할 수 있습니다.
• 유전체 연구 : 유전체 연구에 대한 투자 증가는 생체분자 소프트웨어의 성장을 촉진합니다. 생명공학 연구가 발전함에 따라 고급 유전자 도구의 필요성이 계속 증가하고 있습니다.
• 생명공학 스타트업과의 제휴 : 생명공학 스타트업 및 연구기관과의 협업을 통한 혁신은 새로운 생체분자 소프트웨어 애플리케이션 개발에 박차를 가할 수 있는 큰 성장 기회가 될 것입니다.
• 클라우드 기반 연구 플랫폼 : 생체분자 소프트웨어에 클라우드 기반 기술을 도입하여 연구 데이터의 효율적인 저장 및 공유가 가능해져 연구 역량 확대 및 공동 연구 촉진에 도움이 될 것으로 기대됩니다.

이러한 성장 기회는 생체분자 소프트웨어 시장을 재편하고, 그 범위를 확장하며, 학술 및 임상 분야에서 생명공학의 진화를 촉진할 것입니다.

생체분자 소프트웨어 시장 촉진요인 및 과제

생체분자 소프트웨어 시장은 기술 발전, 경제적 요인, 규제 문제 등 다양한 시장 촉진요인 및 과제에 영향을 받고 있습니다. 이러한 요인을 이해하는 것은 시장을 탐색하고 성장을 달성하는 데 매우 중요합니다.

생체분자 소프트웨어 시장을 이끄는 요인은 다음과 같습니다:

• 기술 발전 : AI, 머신러닝, 데이터 분석의 혁신은 더욱 정교한 생체분자 소프트웨어의 개발을 촉진하고, 연구 역량과 신약 개발 프로세스를 강화하고 있습니다.
• 연구 자금의 증가 : 생의학 및 생명공학 연구에 대한 투자 증가는 첨단 생체분자 소프트웨어에 대한 수요를 촉진하고 있습니다. 자금 지원의 증가는 신기술의 개발 및 채택을 지원합니다.
• 맞춤형 의료에 대한 관심 : 맞춤형 의료로의 전환은 정확한 분자 분석과 맞춤형 치료 계획을 가능하게 하는 소프트웨어에 대한 수요를 촉진하고 시장을 확대시키고 있습니다.
• 생명공학 분야의 확대 : 생명공학 분야의 급격한 성장은 생명공학 기업들이 조사개발을 위해 첨단 소프트웨어 솔루션을 필요로 하기 때문에 생명공학 분야의 급격한 성장은 생체분자 소프트웨어 개발의 기회를 창출하고 있습니다.
• 세계 협업 : 연구 개발의 국제적인 협업이 증가함에 따라 생체분자 소프트웨어의 도입이 촉진되고, 데이터 공유가 지원되며, 혁신이 촉진될 것입니다.

생체분자 소프트웨어 시장의 과제는 다음과 같습니다:

• 높은 개발 비용 : 이 분야의 기업들은 새로운 첨단 생체분자 소프트웨어 개발과 관련된 높은 비용으로 인해 높은 진입장벽에 직면해 있습니다.
• 규제 대응 : 생체분자 소프트웨어의 시장 진입과 실용화에는 엄격한 규제 준수가 필요하기 때문에 규제 요건 준수가 큰 과제입니다.
• 보안 문제 : 생체분자 소프트웨어에서 데이터의 기밀성과 보안을 보호하는 것은 신뢰성과 컴플라이언스를 유지하는 데 매우 중요합니다.
• 기존 시스템과의 통합 : 새로운 생체분자 소프트웨어를 기존 시스템 및 워크플로우와 통합하는 것은 어려운 일입니다. 호환성을 보장하고 통합을 용이하게 하는 것은 사용자 채택을 위해 매우 중요합니다.
• 시장 경쟁 : 소프트웨어 벤더 간의 치열한 가격 경쟁으로 인해 시장 점유율이 하락할 수 있습니다. 기업은 경쟁력을 유지하기 위해 지속적인 혁신과 차별화를 추구해야 합니다.

이러한 시장 촉진요인과 도전과제는 바이오 분자 소프트웨어 시장에서 기술, 규제, 전략의 역할을 강조하고 있습니다. 이 산업에서 성공하기 위해서는 이러한 요소들이 효과적으로 균형을 이루어야 합니다.

목차

제1장 주요 요약

제2장 세계의 생체분자 소프트웨어 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 생체분자 소프트웨어 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 생체분자 소프트웨어 시장 : 기능 종류별
  • Windows
  • Linux
  • MacOS
• 세계의 생체분자 소프트웨어 시장 : 용도별
  • 병원
  • 진료소
  • 연구 센터

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 생체분자 소프트웨어 시장 : 지역별
• 북미의 생체분자 소프트웨어 시장
• 유럽의 생체분자 소프트웨어 시장
• 아시아태평양의 생체분자 소프트웨어 시장
• 기타 지역의 생체분자 소프트웨어 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 생체분자 소프트웨어 시장 성장 기회 : 기능 종류별
  • 세계의 생체분자 소프트웨어 시장 성장 기회 : 용도별
  • 세계의 생체분자 소프트웨어 시장 성장 기회 : 지역별
• 세계의 생체분자 소프트웨어 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 생체분자 소프트웨어 시장 생산능력 확대
  • 세계의 생체분자 소프트웨어 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Hamilton Thorne
• Hermes Medical Solution
• INDICAL BIOSCIENCE
• Lexogen

영문목차

The future of the global biomolecule software market looks promising with opportunities in the hospital, clinic, and research center markets. The global biomolecule software market is expected to grow with a CAGR of 15.0% from 2025 to 2031. The major drivers for this market are the increasing demand for biomolecule software in drug discovery and development and the growing adoption of personalized medicine.

• Lucintel forecasts that, within the function type category, the window segment is expected to witness the highest growth over the forecast period due to ease of use and compatibility with existing infrastructure.
• Within the application category, the hospital is expected to witness the highest growth due to the growing demand for analyzing patient data, identifying drug targets, and developing personalized treatment plans.
• In terms of region, North America will remain the largest region over the forecast period due to the strong pharmaceutical and biotechnology industry.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biomolecule Software Market

The biomolecule software market is evolving with several emerging trends that are driving innovation and shaping the future of biomolecular research and applications. These trends reflect advancements in technology and increasing demand for precise biomolecular analysis.

• Artificial Intelligence and Machine Learning Paradigm: AI and machine learning aspects are now included in biomolecule software to aid in predictive analysis and data mining. The integration is resulting in increased precision in the areas of drug development and biomolecular study.
• Cloud Computing: Cloud technology is playing a more vital role in biomolecule software by offering endless computing and storage power. This eases communication and sharing of data between various research institutions and biotechnology companies.
• Upgrades in Data Management: Due to the growing complexity of the software and data structures, enhancements are being added to better understand biomolecular data. This trend contributes to a broader range of studies and approaches to treatment in medicine.
• Rationale for this Trend: There has been a growing shift of focus by the developers of biomolecule software toward more personalized medicine parameters. This change is driven by advances in genomic technology and the analysis of individual patient data.
• Expansion of Drug Discovery Platforms: As more biopharma companies come to appreciate the need for integrated drug discovery platforms, rapid development is occurring within biomolecule software tools and systems. These platforms incorporate numerous instruments to make the drug development process easier and faster.

These trends are transforming the biomolecule software market in terms of data interpretation and research. They are encouraging novelty and broadening the application of biomolecule software across various sectors.

Recent Developments in the Biomolecule Software Market

New entrants in the biomolecule software market have brought about positive changes in technology, collaboration, and scope of application. These developments are affecting the market and fast-tracking the progress of biomolecular research and drug development.

• AI-Driven Research Tools: Incorporating AI into biomolecule software systems is improving research quality through enhanced data analyses and predictive modeling. This accelerates drug discovery and biomolecular research.
• Cloud-Based Data Management: The utilization of cloud-enabled methods is changing biomolecule software by offering flexible and sufficient memory and computing power, facilitating data sharing and collaboration across institutions.
• Advanced Analytics Capabilities: Modern analytics incorporated into biomolecule software offer new solutions for addressing complex biomolecular data, enhancing research output and personalized therapy.
• Enhanced Drug Discovery Platforms: The creation of advanced drug discovery tools within biomolecule software is improving efficiency in drug development by combining several tools and datasets.
• Collaborative Research Initiatives: Collaborations between biotech companies and academic institutions have increased, leading to new solutions in biomolecule software. These initiatives are promoting genomics and personalized medicine research.

These advancements have benefitted the biomolecule software market through improved research, better data management, and increased collaboration, driving market growth and innovation.

Strategic Growth Opportunities for Biomolecule Software Market

The biomolecule software market presents various strategic growth opportunities in terms of application. Focusing on these areas will expand the market and advance technologies, promoting biomolecular research and drug discovery.

• Drug Discovery and Development: Expanding drug discovery platforms creates significant growth potential by integrating advanced analytics and AI tools into the process, enabling faster and more efficient drug development.
• Personalized Medicine Solutions: Developing software systems for personalized medicine offers the potential for customized treatment plans tailored to molecular and genetic profiles, improving patient outcomes.
• Genomic Studies: Increased investment in genomics research will drive growth in biomolecule software. The need for advanced genetic tools continues to grow as biotech research progresses.
• Biotech Startups and Collaborations: Innovations driven by collaborations with biotech startups and research institutions offer significant growth opportunities, fueling the development of new biomolecule software applications.
• Cloud-Based Research Platforms: The adoption of cloud-based technologies in biomolecule software enables effective storage and sharing of research data, expanding research capabilities and fostering collaboration.

These growth opportunities are reshaping the biomolecule software market, expanding its scope, and driving the evolution of biotechnology in academic and clinical settings.

Biomolecule Software Market Driver and Challenges

The biomolecule software market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is crucial for navigating the market and achieving growth.

The factors responsible for driving the biomolecule software market include:

• Technological Advancements: Innovations in AI, machine learning, and data analytics are driving the development of more sophisticated biomolecule software, enhancing research capabilities and drug discovery processes.
• Increased Research Funding: Growing investments in biomedical and biotech research are fueling demand for advanced biomolecule software. Increased funding supports the development and adoption of new technologies.
• Focus on Personalized Medicine: The shift towards personalized medicine is driving demand for software that enables precise molecular analysis and individualized treatment plans, expanding the market.
• Expansion of Biotech Sector: The rapid growth of the biotech sector is creating opportunities for biomolecule software development, as biotech companies require advanced software solutions for research and development.
• Global Collaboration: Increased international collaboration in research and development is promoting the adoption of biomolecule software, supporting data sharing and driving innovation.

Challenges in the biomolecule software market include:

• High Development Costs: Companies in this field face high entry barriers due to the high costs associated with developing new and advanced biomolecule software.
• Regulatory Compliance: Complying with regulatory requirements poses a significant challenge, as participation in the market and practical use of biomolecule software necessitate adherence to strict regulations.
• Security Issues: Protecting the confidentiality and security of data in biomolecule software is critical to maintaining credibility and compliance.
• Integration with Existing Systems: Integrating new biomolecule software with existing systems and workflows can be challenging. Ensuring compatibility and ease of integration is crucial for user adoption.
• Market Competition: Intense price competition among software vendors can result in a loss of market share. Companies must continually innovate and differentiate to stay competitive.

These drivers and challenges highlight the role of technology, regulation, and strategy in the biomolecule software market. Success in this industry requires balancing these factors effectively.

List of Biomolecule Software Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. through these strategies biomolecule software companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomolecule software companies profiled in this report include-

• Hamilton Thorne
• Hermes Medical Solution
• INDICAL BIOSCIENCE
• Lexogen

Biomolecule Software by Segment

The study includes a forecast for the global biomolecule software market by function type, application, and region.

Biomolecule Software Market by Function Type [Analysis by Value from 2019 to 2031]:

• Windows
• Linux
• MacOS

Biomolecule Software Market by Application [Analysis by Value from 2019 to 2031]:

• Hospital
• Clinic
• Research Center

Biomolecule Software Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biomolecule Software Market

Major players in the biomolecule software market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are highlights of recent developments by major biomolecule software producers in key regions: the USA, China, India, Japan, and Germany.

• United States: The U.S. biomolecule software industry is experiencing rapid growth due to advancements in AI and machine learning. These technologies are accelerating drug discovery and enhancing the accuracy of biomolecular research.
• China: In China, biomolecule software is growing rapidly, with an emphasis on leveraging big data analytics and cloud computing. This expansion is benefiting the country's biopharmaceutical sector and improving research capacity.
• Germany: In Germany, there is a strong trend towards collaborations between universities and biotech companies. These partnerships are expanding the use of biomolecule software in genomics and personalized medicine, bolstering the country's biomedical research capabilities.
• India: In India, biomolecule software is proliferating as more funds are invested in biotechnology ventures and research institutions. The focus is on creating cost-effective, scalable drug development and molecular analysis tools.
• Japan: Japan leads in developing new biomolecule software, focusing on integrating advanced imaging solutions with bioinformatics. This approach is enhancing the country's capabilities in molecular medicine and diagnostics.

Features of the Global Biomolecule Software Market

Market Size Estimates: Biomolecule software market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Biomolecule software market size by various segments, such as by function type, application, and region in terms of value ($B).

Regional Analysis: Biomolecule software market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different function types, applications, and regions for the biomolecule software market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomolecule software market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biomolecule software market by function type (windows, linux, and macOS), application (hospital, clinic, and research center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomolecule Software Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Biomolecule Software Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Biomolecule Software Market by Function Type
  • 3.3.1: Windows
  • 3.3.2: Linux
  • 3.3.3: MacOS
• 3.4: Global Biomolecule Software Market by Application
  • 3.4.1: Hospital
  • 3.4.2: Clinic
  • 3.4.3: Research Center

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Biomolecule Software Market by Region
• 4.2: North American Biomolecule Software Market
  • 4.2.1: North American Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
  • 4.2.2: North American Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
• 4.3: European Biomolecule Software Market
  • 4.3.1: European Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
  • 4.3.2: European Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
• 4.4: APAC Biomolecule Software Market
  • 4.4.1: APAC Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
  • 4.4.2: APAC Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
• 4.5: ROW Biomolecule Software Market
  • 4.5.1: ROW Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
  • 4.5.2: ROW Biomolecule Software Market by Application: Hospital, Clinic, and Research Center

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biomolecule Software Market by Function Type
  • 6.1.2: Growth Opportunities for the Global Biomolecule Software Market by Application
  • 6.1.3: Growth Opportunities for the Global Biomolecule Software Market by Region
• 6.2: Emerging Trends in the Global Biomolecule Software Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biomolecule Software Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomolecule Software Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hamilton Thorne
• 7.2: Hermes Medical Solution
• 7.3: INDICAL BIOSCIENCE
• 7.4: Lexogen